Ginwa Enterprise Group (SHSE:600080) Notes Receivable: ¥0.0 Mil (As of Mar. 2026)


SHSE:600080 Ginwa Enterprise Group Inc SHSE:600080
47 GF Score
Price ¥4.94
GF Value ¥7.53
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Ginwa Enterprise Group Notes Receivable?

Ginwa Enterprise Group SHSE:600080 -1.20% 47 Notes Receivable is ¥0.0 Mil as of Mar. 2026. GuruFocus rates SHSE:600080 with a GF Score™ of 47/100 and a GF Value™ of ¥7.53 (Possible Value Trap). The stock has 2 warning signs investors should review.

Ginwa Enterprise Group's Notes Receivable for the quarter that ended in Mar. 2026 was ¥0.0 Mil.

Ginwa Enterprise Group Notes Receivable Related Terms

Ginwa Enterprise Group Notes Receivable Historical Data

* Premium members only.

The historical data trend for Ginwa Enterprise Group's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ginwa Enterprise Group Notes Receivable Chart

Ginwa Enterprise Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Ginwa Enterprise Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
SHSE:600080
47GF Score
Ginwa Enterprise Group Inc SHSE:600080
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ginwa Enterprise Group Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of ¥0.0 Mil mean?
Ginwa Enterprise Group (SHSE:600080) has a Notes Receivable of ¥0.0 Mil as of Mar. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Ginwa Enterprise Group and its competitors.
Is Ginwa Enterprise Group's Notes Receivable too high?
Ginwa Enterprise Group's current Notes Receivable is ¥0.0 Mil. Overall, Ginwa Enterprise Group has a GF Score™ of 47/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Ginwa Enterprise Group's Notes Receivable compare to ZTS and UTHR?
Ginwa Enterprise Group's Notes Receivable of ¥0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Drug Manufacturers company?
A good Notes Receivable depends on the Drug Manufacturers industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Ginwa Enterprise Group and its competitors. Ginwa Enterprise Group's current Notes Receivable is ¥0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ginwa Enterprise Group stock overvalued right now?
Based on GuruFocus' analysis, Ginwa Enterprise Group (SHSE:600080) is currently considered Possible Value Trap. The stock's GF Value™ is ¥7.53, compared to a current price of ¥4.94 — trading 34.4% below its estimated fair value. The current Notes Receivable is ¥0.0 Mil. Ginwa Enterprise Group's overall GF Score™ is 47/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Ginwa Enterprise Group (SHSE:600080), the current Notes Receivable is ¥0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ginwa Enterprise Group (SHSE:600080) Overvalued in 2026?

Based on GuruFocus' analysis, Ginwa Enterprise Group stock appears to be undervalued. The current stock price of ¥4.94 is trading 34.4% below its estimated GF Value™ of ¥7.53. GuruFocus considers Ginwa Enterprise Group to be Possible Value Trap.

Key valuation signals for SHSE:600080:

  • Notes Receivable: ¥0.0 Mil
  • GF Value™: ¥7.53 vs. price of ¥4.94 (34.4% below fair value)
  • GF Score™: 47/100 with 2 warning signs

No single metric tells the full story. See the SHSE:600080 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ginwa Enterprise Group Business Description

Address Gaoxin 3rd Road, 40th Floor, South Tower, Phase III, Fortune Center, Gaoxin District, Xi'an, CHN, 710075
Ginwa Enterprise Group Inc operates in the pharmaceutical industry. The main business is the research and development, production, and sales of drugs, and the product line covers chemical drugs, Chinese patent medicines, raw materials, and health products. The dosage forms include tablets, capsules, granules, powders, mixtures, oral solutions, syrups, external solutions, and more than 100 varieties and specifications.
47GF Score

Get the complete analysis for SHSE:600080

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥4.94
Price
¥7.53
GF Value